Open Access

Aripiprazole exerts a neuroprotective effect in mouse focal cerebral ischemia

  • Authors:
    • Chan H. Gil
    • Yu R. Kim
    • Hong J. Lee
    • Da H. Jung
    • Hwa K. Shin
    • Byung T. Choi
  • View Affiliations

  • Published online on: November 6, 2017     https://doi.org/10.3892/etm.2017.5443
  • Pages: 745-750
  • Copyright: © Gil et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Previous studies have demonstrated that aripiprazole (APZ), a third‑generation atypical antipsychotic drug, exhibits anti‑depressant and neuroprotective effects by promoting dopaminergic neuronal cell recovery in stroke. To investigate the neuroprotective effects of APZ, behavioral and histopathological experiments were performed in the current study a mouse model of middle cerebral artery occlusion (MCAO)‑induced ischemia following administration of APZ. The subacute phase of ischemic assaults was divided into 3 periods, each with a duration of 5 days, according to the start of APZ (3 mg/kg) administration (1‑5, 5‑9 or 10‑14 days following MCAO). The beneficial effects of APZ on motor behavior demonstrated in the cylinder, rotarod and wire suspension tests were greatest when APZ was administered 1‑5 days following MCAO, with clear improvements in motor function compared with vehicle‑treated mice. Histopathological analysis revealed that prominent atrophic changes occurred in the striatum of MCAO mice and that these changes were reduced following APZ treatment. APZ also attenuated dopaminergic neuronal injury in the striatum. Cell death and microglial activation were decreased and the expression of Ca2+/calmodulin‑dependent protein kinase II δ was enhanced following APZ treatment. These results indicate that the atypical antipsychotic drug, APZ, exhibits a neuroprotective effect in dopaminergic neuronal cells that may improve behavioral function following ischemic stroke.
View Figures
View References

Related Articles

Journal Cover

January-2018
Volume 15 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gil CH, Kim YR, Lee HJ, Jung DH, Shin HK and Choi BT: Aripiprazole exerts a neuroprotective effect in mouse focal cerebral ischemia. Exp Ther Med 15: 745-750, 2018
APA
Gil, C.H., Kim, Y.R., Lee, H.J., Jung, D.H., Shin, H.K., & Choi, B.T. (2018). Aripiprazole exerts a neuroprotective effect in mouse focal cerebral ischemia. Experimental and Therapeutic Medicine, 15, 745-750. https://doi.org/10.3892/etm.2017.5443
MLA
Gil, C. H., Kim, Y. R., Lee, H. J., Jung, D. H., Shin, H. K., Choi, B. T."Aripiprazole exerts a neuroprotective effect in mouse focal cerebral ischemia". Experimental and Therapeutic Medicine 15.1 (2018): 745-750.
Chicago
Gil, C. H., Kim, Y. R., Lee, H. J., Jung, D. H., Shin, H. K., Choi, B. T."Aripiprazole exerts a neuroprotective effect in mouse focal cerebral ischemia". Experimental and Therapeutic Medicine 15, no. 1 (2018): 745-750. https://doi.org/10.3892/etm.2017.5443